Search All News
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
- October 16, 2012
Cancer patients at NY-Presbyterian/CUMC will have access to a new free American Cancer Society program that provides resources & support.
Source:New York Daily NewsOctober 5, 2012
Dr. Alfred Neugut plans to analyze how costs & other factors affect breast cancer treatment adherence--study sponsored by American Cancer Society
- September 28, 2012
CUMC's Dr. Megan Sykes talks to "The Takeaway" about mouse stand-ins leading the way towards cures, treatment for patients.
Source:The New York TimesSeptember 26, 2012
Megan Sykes, a medical researcher at Columbia, has a mouse with a human immune system — her own. She calls it “Mini-Me.”
- September 20, 2012
Columbia University Medical Center (CUMC) is one of 50 institutions selected nationwide from more than 700 applications for a “Provocative Questions” grant from the National Cancer Institute (NCI).
- September 5, 2012
David Brenner, PhD, DSc, discusses three aspects of radiation and CT scans—quality control, training, and overuse—that urgently need addressing.
- July 30, 2012
A common & aggressive brain cancer appears to be caused by a genetic mutation -- and targeting it with a drug showed promise in mice.
- July 26, 2012
Some cases of glioblastoma, the most common & aggressive form of brain cancer, are caused by the fusion of 2 adjacent genes.
- June 4, 2012
With this new gift, Mr. and Mrs. Irving have generously committed nearly $200 million to CUMC and its partner, NewYork-Presbyterian Hospital/Columbia.